Boan Biological (06955.HK): The application for marketing authorization of two types of Denosumab Injection has been accepted in the UK.
Zhixin Finance APP News, BorgAngen Biosciences (06955.HK) announced that the company's application for UK marketing authorization for self-developed Denosumab injection 60mg (BA6101) in the field of orthopedics and Denosumab injection 120mg (BA1102) in the field of oncology has been accepted by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK.
Latest
3 m ago

